Phosphodiesterase inhibitors: The inotropes of choice for the new millennium?

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 14, Issue 4, 2000, Pages 365-366

  Levy, Jerrold H ^a   Bailey, James M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; AMRINONE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG INDICATION; EDITORIAL; ENZYME ACTIVITY; HEART FAILURE; INOTROPISM; PRIORITY JOURNAL;

EID: 0033869526     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2000.7919     Document Type: Article

References (13)

1. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors
2. A comparative evaluation of the effects of multiple vasodilators on human internal mammary artery
3. Pharmacokinetics of amrinone during cardiac surgery
4. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery
5. Effects of phosphodiesterase inhibitors on the human internal mammary artery
6. The effect of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass
7. Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients
8. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery
9. Milrinone modulates endotoxemia, systemic inflammation, and subsequent acute phase response after cardiopulmonary bypass (CPB)
10. The pharmacokinetics and pharmacodynamics of milrinone in pediatric patients after cardiac surgery
11. Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery
12. Amrinone: Its effect on vascular resistance and capacitance in humans